Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.24% | 165.22 | 0.7% | $1347.13m | |
| LLY | Eli Lilly & Co. | 1.47% | 326.29 | 1.1% | $1083.43m | |
| ABBV | AbbVie, Inc. | 1.65% | 140.60 | 1.9% | $866.31m | |
| PFE | Pfizer Inc. | 1.34% | 44.73 | 0.9% | $808.83m | |
| BMY | Bristol-Myers Squibb Co. | 1.28% | 71.43 | 1.0% | $782.53m | |
| MRK | Merck & Co., Inc. | 1.03% | 88.45 | 0.7% | $717.67m | |
| AZN | AstraZeneca Plc | 2.18% | 56.76 | 1.0% | $395.93m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 1.33% | 199.41 | 8.2% | $220.28m | |
| GSK | GSK Plc | 2.15% | 30.90 | 0.3% | $214.16m | |
| NVS | Novartis AG | 1.79% | 78.04 | 0.2% | $205.26m | |
| GBT | Global Blood Therapeutics, Inc. | -0.01% | 68.48 | 5.4% | $191.16m | |
| IDXX | IDEXX Laboratories, Inc. | 3.69% | 349.11 | 3.9% | $191.09m | |
| HZNP | Horizon Therapeutics Plc | 2.86% | 66.10 | 5.4% | $178.62m | |
| ATXI | Avenue Therapeutics, Inc. | 26.50% | 14.56 | 0.0% | $176.22m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.72% | 111.83 | 12.4% | $139.09m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.